UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Crohn's Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease

Scandinavian journal of gastroenterology, 2020-12, Vol.55 (12), p.1419-1426

2020

Volltextzugriff (PDF)

Infliximab‐related weight gain in inflammatory bowel disease: associations and financial impacts

Internal medicine journal, 2020-09, Vol.50 (9), p.1134-1138

2020

Volltextzugriff (PDF)

Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease

Digestive diseases and sciences, 2023-03, Vol.68 (3), p.889-896

2023

Volltextzugriff (PDF)

Mo1800 - Psychological Care is Needed and Welcomed by Patients with Inflammatory Bowel Disease under Routine Care

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-806-S-806

2018

Volltextzugriff (PDF)

Tu1020 - Crohn's Colitis Care (CCcare) - Development and Testing of a Bespoke Cloud-Based Clinical Management System for Inflammatory Bowel Disease (IBD)

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-892-S-892

2018

Volltextzugriff (PDF)

Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease

Inflammatory bowel diseases, 2018-12, Vol.24 (12), p.2606-2612

2018

Volltextzugriff (PDF)

Tu1330 Thiopurine Metabolite Testing to Guide Management in Inflammatory Bowel Disease (IBD) Yields Clinical Benefit At 12 Months: A Retrospective Observational Study

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-861-S-861

2015

Volltextzugriff (PDF)

Tu1331 Are We Under-Recognizing Skewed Thiopurine Metabolism in IBD Patients? Routine Thiopurine Metabolite Measurement Yields Clinical Benefit at 12 Months: A Retrospective Observational Study

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-861-S-861

2015

Volltextzugriff (PDF)

Benefits of Exclusive Enteral Nutrition in Adults With Complex Active Crohn’s Disease: A Case Series of 13 Consecutive Patients

Crohn's & colitis 360, 2019-10, Vol.1 (3)

2019

Volltextzugriff (PDF)

Corrigendum: PACSIN2 Does Not Influence Thiopurine-Related Toxicity in Patients With Inflammatory Bowel Disease

The American journal of gastroenterology, 2015-01, Vol.110 (1), p.204

2015

Volltextzugriff (PDF)

PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease

The American journal of gastroenterology, 2014-06, Vol.109 (6), p.925-927

2014

Volltextzugriff (PDF)

Mo1265 More Targeted Evaluation of Nutrition in Inflammatory Bowel Disease (IBD) Reveals Opportunities to Optimise Care: Body Mass Index, Body Composition and Iron Deficiency

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-601-S-602

2014

Volltextzugriff (PDF)

Crohn's disease and smoking: Is it ever too late to quit?

Journal of Crohn's and colitis, 2013-12, Vol.7 (12), p.e665-e671

2013

Volltextzugriff (PDF)

Integrated psychological care in Inflammatory Bowel Disease outpatients: Early data from a new initiative

International journal of integrated care, 2017-07, Vol.17 (3), p.39

2017

Volltextzugriff (PDF)

Mo1311 Body Mass Index (BMI) Is Better At Predicting Fat Mass Than Muscle Mass in Inflammatory Bowel Disease (IBD) Patients

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-633-S-634

2013

Volltextzugriff (PDF)

761 The Effect of Perianal Disease on Perceived Severity of Crohn's Disease (CD)

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-105-S-105

2010

Volltextzugriff (PDF)

M1037 Introduction of a Dedicated IBD Service Quantitatively and Qualitatively Improves Outcomes in Less Than 18 Months: A Prospective Cohort Study in a Large Metropolitan Centre

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-318-S-318

2010

Volltextzugriff (PDF)

A dedicated inflammatory bowel disease service quantitatively and qualitatively improves outcomes in less than 18 months: a prospective cohort study in a large metropolitan centre

Frontline gastroenterology, 2012-07, Vol.3 (3), p.137-142

2012

Volltextzugriff (PDF)

Sa1282 Colectomy for Ulcerative Colitis Across Australia and New Zealand: Indications, Risk Factors and Rates - an ANZ IBD Consortium Study

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-262-S-262

2012

Volltextzugriff (PDF)

Sa1921 Predicting Long-Term Response to Anti-TNF Therapy in Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-360-S-360

2012

Volltextzugriff (PDF)

Smoking Cessation Following the Diagnosis of Crohn's Disease Still Reduces the Rates of Surgery and Complicated Disease

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-429-S-429

2011

Volltextzugriff (PDF)

Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study

Journal of Crohn's and colitis, 2012-04, Vol.6 (3), p.287-293

2012

Volltextzugriff (PDF)

Single-case disconnectome lesion-symptom mapping: Identifying two subtypes of limb apraxia

Neuropsychologia, 2022-06, Vol.170, p.108210-108210, Article 108210

2022

Volltextzugriff (PDF)

Evolving methodology of national tobacco control investment cases

Tobacco control, 2024-05, Vol.33 (Suppl 1), p.s10-s16

2024

Volltextzugriff (PDF)

Interpreting results, impacts and implications from WHO FCTC tobacco control investment cases in 21 low-income and middle-income countries

Tobacco control, 2024-05, Vol.33 (Suppl 1), p.s17-s26

2024

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(33)
Bücher
(1)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Humans
(11)
Gastroenterology And Hepatology
(9)
Gastroenterology & Hepatology
(7)
Inflammatory Bowel Disease
(7)
Male
(5)
Female
(4)
Adult
(3)
Crohn's Disease
(3)
Gastroenterology
(3)
Inflammatory Bowel Diseases - Drug Therapy
(3)
Middle Aged
(3)
Mortality
(3)
Public, Environmental & Occupational Health
(3)
Young Adult
(3)
Advocacy
(2)
Audits
(2)
Azathioprine
(2)
Cohort Studies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Crohn's Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease

Infliximab‐related weight gain in inflammatory bowel disease: associations and financial impacts

Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease

Mo1800 - Psychological Care is Needed and Welcomed by Patients with Inflammatory Bowel Disease under Routine Care

Tu1020 - Crohn's Colitis Care (CCcare) - Development and Testing of a Bespoke Cloud-Based Clinical Management System for Inflammatory Bowel Disease (IBD)

Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease

Tu1330 Thiopurine Metabolite Testing to Guide Management in Inflammatory Bowel Disease (IBD) Yields Clinical Benefit At 12 Months: A Retrospective Observational Study

Tu1331 Are We Under-Recognizing Skewed Thiopurine Metabolism in IBD Patients? Routine Thiopurine Metabolite Measurement Yields Clinical Benefit at 12 Months: A Retrospective Observational Study

Benefits of Exclusive Enteral Nutrition in Adults With Complex Active Crohn’s Disease: A Case Series of 13 Consecutive Patients

Corrigendum: PACSIN2 Does Not Influence Thiopurine-Related Toxicity in Patients With Inflammatory Bowel Disease

PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease

Mo1265 More Targeted Evaluation of Nutrition in Inflammatory Bowel Disease (IBD) Reveals Opportunities to Optimise Care: Body Mass Index, Body Composition and Iron Deficiency

Crohn's disease and smoking: Is it ever too late to quit?

Integrated psychological care in Inflammatory Bowel Disease outpatients: Early data from a new initiative

Mo1311 Body Mass Index (BMI) Is Better At Predicting Fat Mass Than Muscle Mass in Inflammatory Bowel Disease (IBD) Patients

761 The Effect of Perianal Disease on Perceived Severity of Crohn's Disease (CD)

M1037 Introduction of a Dedicated IBD Service Quantitatively and Qualitatively Improves Outcomes in Less Than 18 Months: A Prospective Cohort Study in a Large Metropolitan Centre

A dedicated inflammatory bowel disease service quantitatively and qualitatively improves outcomes in less than 18 months: a prospective cohort study in a large metropolitan centre

Sa1282 Colectomy for Ulcerative Colitis Across Australia and New Zealand: Indications, Risk Factors and Rates - an ANZ IBD Consortium Study

Sa1921 Predicting Long-Term Response to Anti-TNF Therapy in Crohn's Disease

Smoking Cessation Following the Diagnosis of Crohn's Disease Still Reduces the Rates of Surgery and Complicated Disease

Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study

Single-case disconnectome lesion-symptom mapping: Identifying two subtypes of limb apraxia

Evolving methodology of national tobacco control investment cases

Interpreting results, impacts and implications from WHO FCTC tobacco control investment cases in 21 low-income and middle-income countries

Suchergebnisse filtern